Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Pashayan, Nora; Antoniou, Antonis C.; Ivanus, Urska; Esserman, Laura J.; Easton, Douglas F.; French, David; Sroczynski, Gaby; Hall, Per; Cuzick, Jack; Evans, D. Gareth; Simard, Jacques; Garcia-Closas, Montserrat; Schmutzler, Rita; Wegwarth, Odette; Pharoah, Paul; Moorthie, Sowmiya; De Montgolfier, Sandrine; Baron, Camille; Herceg, Zdenko; Turnbull, Clare; Balleyguier, Corinne; Rossi, Paolo Giorgi; Wesseling, Jelle; Ritchie, David; Tischkowitz, Marc; Broeders, Mireille; Reisel, Dan; Metspalu, Andres; Callender, Thomas; de Koning, Harry; Devilee, Peter; Delaloge, Suzette; Schmidt, Marjanka K.; Widschwendter, Martin

doi:10.1038/s41571-020-0412-0

Download PDF

Publisher Correction
Published: 29 June 2020

Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Nature Reviews Clinical Oncology volume 17, page 716 (2020)Cite this article

1481 Accesses
8 Citations
Metrics details

The Original Article was published on 18 June 2020

Nature Reviews Clinical Oncology (2020) https://doi.org/10.1038/s41571-020-0388-9 Published online 18 June 2020

This paper was originally published without open access. As of the date of this correction, the paper is available online as an open-access paper under a Creative Commons Attribution 4.0 International License.

Author information

Authors and Affiliations

Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK
Nora Pashayan & Thomas Callender
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Antonis C. Antoniou, Douglas F. Easton & Paul Pharoah
Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Urska Ivanus
Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA
Laura J. Esserman
Division of Psychology & Mental Health, School of Health Sciences, University of Manchester, Manchester, UK
David French
Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria
Gaby Sroczynski
Division of Health Technology Assessment, Oncotyrol — Center for Personalized Cancer Medicine, Innsbruck, Austria
Gaby Sroczynski
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Per Hall
Department of Oncology, Södersjukhuset, Stockholm, Sweden
Per Hall
Wolfson Institute of Preventive Medicine, Barts and The London, Centre for Cancer Prevention, Queen Mary University of London, London, UK
Jack Cuzick
Division of Evolution and Genomic Sciences, University of Manchester, Manchester, UK
D. Gareth Evans
Genomics Center, CHU de Québec — Université Laval Research Center, Québec, Canada
Jacques Simard
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Montserrat Garcia-Closas
Center of Family Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany
Rita Schmutzler
Max Planck Institute for Human Development, Center for Adaptive Rationality, Harding Center for Risk Literacy, Berlin, Germany
Odette Wegwarth
Department of Oncology, University of Cambridge, Cambridge, UK
Paul Pharoah
PHG Foundation, Cambridge, UK
Sowmiya Moorthie
IRIS Institute for Interdisciplinary Research on Social Issues, Paris, France
Sandrine De Montgolfier
Unicancer, Paris, France
Camille Baron
Epigenetic Group, International Agency for Research on Cancer (IARC), WHO, Lyon, France
Zdenko Herceg
Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
Clare Turnbull
Department Medical Imaging, Institut Gustave Roussy, Villejuif, France
Corinne Balleyguier
Epidemiology Unit, Azienda USL di Reggio Emilia — IRCCS, Reggio Emilia, Italy
Paolo Giorgi Rossi
Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands
Jelle Wesseling & Marjanka K. Schmidt
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
David Ritchie
Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK
Marc Tischkowitz
Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands
Mireille Broeders
Department of Women’s Cancer, Institute for Women’s Health, University College London, London, UK
Dan Reisel & Martin Widschwendter
The Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia
Andres Metspalu
Department of Public Health, Erasmus MC, Rotterdam, Netherlands
Harry de Koning
Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands
Peter Devilee
Breast Cancer Department, Gustave Roussy Institute, Paris, France
Suzette Delaloge
Universität Innsbruck, Innsbruck, Austria
Martin Widschwendter
European Translational Oncology Prevention and Screening (EUTOPS) Institute, Hall in Tirol, Austria
Martin Widschwendter

Authors

Nora Pashayan
View author publications
You can also search for this author in PubMed Google Scholar
Antonis C. Antoniou
View author publications
You can also search for this author in PubMed Google Scholar
Urska Ivanus
View author publications
You can also search for this author in PubMed Google Scholar
Laura J. Esserman
View author publications
You can also search for this author in PubMed Google Scholar
Douglas F. Easton
View author publications
You can also search for this author in PubMed Google Scholar
David French
View author publications
You can also search for this author in PubMed Google Scholar
Gaby Sroczynski
View author publications
You can also search for this author in PubMed Google Scholar
Per Hall
View author publications
You can also search for this author in PubMed Google Scholar
Jack Cuzick
View author publications
You can also search for this author in PubMed Google Scholar
D. Gareth Evans
View author publications
You can also search for this author in PubMed Google Scholar
Jacques Simard
View author publications
You can also search for this author in PubMed Google Scholar
Montserrat Garcia-Closas
View author publications
You can also search for this author in PubMed Google Scholar
Rita Schmutzler
View author publications
You can also search for this author in PubMed Google Scholar
Odette Wegwarth
View author publications
You can also search for this author in PubMed Google Scholar
Paul Pharoah
View author publications
You can also search for this author in PubMed Google Scholar
Sowmiya Moorthie
View author publications
You can also search for this author in PubMed Google Scholar
Sandrine De Montgolfier
View author publications
You can also search for this author in PubMed Google Scholar
Camille Baron
View author publications
You can also search for this author in PubMed Google Scholar
Zdenko Herceg
View author publications
You can also search for this author in PubMed Google Scholar
Clare Turnbull
View author publications
You can also search for this author in PubMed Google Scholar
Corinne Balleyguier
View author publications
You can also search for this author in PubMed Google Scholar
Paolo Giorgi Rossi
View author publications
You can also search for this author in PubMed Google Scholar
Jelle Wesseling
View author publications
You can also search for this author in PubMed Google Scholar
David Ritchie
View author publications
You can also search for this author in PubMed Google Scholar
Marc Tischkowitz
View author publications
You can also search for this author in PubMed Google Scholar
Mireille Broeders
View author publications
You can also search for this author in PubMed Google Scholar
Dan Reisel
View author publications
You can also search for this author in PubMed Google Scholar
Andres Metspalu
View author publications
You can also search for this author in PubMed Google Scholar
Thomas Callender
View author publications
You can also search for this author in PubMed Google Scholar
Harry de Koning
View author publications
You can also search for this author in PubMed Google Scholar
Peter Devilee
View author publications
You can also search for this author in PubMed Google Scholar
Suzette Delaloge
View author publications
You can also search for this author in PubMed Google Scholar
Marjanka K. Schmidt
View author publications
You can also search for this author in PubMed Google Scholar
Martin Widschwendter
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Widschwendter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pashayan, N., Antoniou, A.C., Ivanus, U. et al. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 17, 716 (2020). https://doi.org/10.1038/s41571-020-0412-0

Download citation

Published: 29 June 2020
Issue Date: November 2020
DOI: https://doi.org/10.1038/s41571-020-0412-0

This article is cited by

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
- D. Gareth Evans
- Lorna McWilliams
- David P. French
British Journal of Cancer (2023)
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
- David P. French
- Susan Astley
- D. Gareth Evans
BMC Cancer (2020)

Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

This article is cited by

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)

Search

Quick links

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

This article is cited by

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)

Search

Quick links